公开(公告)号：US20190276436A1

公开(公告)日：2019-09-12

申请号：US16356882

申请日：2019-03-18

申请人： Eli Lilly and Company

发明人： David Andrew COATES ,  Luo Heng QIN ,  Yi WEI ,  Jingye ZHOU

IPC分类号： C07D403/04 ,  A61P1/16 ,  A61K31/395 ,  A61K31/715 ,  C07D401/04

摘要： The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and RI are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds.

公开(公告)号：US20200262817A1

公开(公告)日：2020-08-20

申请号：US16584622

申请日：2019-09-26

申请人： Eli Lilly and Company

发明人： David Andrew COATES ,  Luo Heng QIN ,  Yi WEI ,  Jingye ZHOU

IPC分类号： C07D403/04 ,  A61K31/715 ,  A61K31/395 ,  C07D401/04 ,  A61P1/16

摘要： The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds,